BioAmber Inc. announced unaudited consolidated earnings results for the fourth quarter and year ended December 31, 2016. For the quarter, product sales were approximately $631,000.  For the year, the company reported product sales of $8,272,000 against $2,172,000 a year ago. The 281% increase relative to the previous year was driven by an increase in the quantity of bio-succinic acid sold from Sarnia operations. Operating loss was $29,630,000 against $38,528,000 a year ago. Loss before income taxes was $28,345,000 against $41,175,000 a year ago. Net loss attributable to the company’s shareholders was $22,478,000 against $37,226,000 a year ago. Net cash used in operating activities was $37,616,000 against $32,199,000 a year ago. Acquisition of property and equipment and intangible asset, net of disposals was $668,000 against $64,390,000 a year ago. Adjusted net loss attributable to company shareholders of $30,766,000, or $1.07 per share compared to $38,047,000 or $1.55 per share a year ago.